Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Rhodin KE, Jung SH, Elleson K, DePalo D, Straker R, McKinley S, Beekman K, Parker L, Chen S, Iyer MK, Salama AKS, Bartlett E, Karakousis G, Zager JS, Tyler DS, Beasley GM.
Rhodin KE, et al. Among authors: beekman k.
Ann Surg Oncol. 2023 Oct;30(11):6340-6352. doi: 10.1245/s10434-023-13935-0. Epub 2023 Jul 22.
Ann Surg Oncol. 2023.
PMID: 37481487
Free PMC article.